Related references
Note: Only part of the references are listed.TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis
Eric Gracey et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Interleukin-23 drives expansion of Thelper 17 cells through epigenetic regulation by signal transducer and activators of transcription 3 in lupus patients
Seunghyun Lee et al.
RHEUMATOLOGY (2020)
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Uddalak Bharadwaj et al.
PHARMACOLOGICAL REVIEWS (2020)
Effects of dihydrotestosterone on osteoblast activity in curdlan-administered SKG mice and osteoprogenitor cells in patients with ankylosing spondylitis
Sungsin Jo et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Assessments of Functioning in Patients With Axial Spondyloarthritis
Uta Kiltz et al.
JOURNAL OF RHEUMATIC DISEASES (2020)
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
Douglas J. Veale et al.
RHEUMATOLOGY (2019)
Identification of myeloid cells in the human enthesis as the main source of local IL-23 production
Charlie Bridgewood et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Evidence that tissue resident human enthesis γδT-cells can produce IL-17A independently of IL-23R transcript expression
Richard James Cuthbert et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription
Yiling Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study
Juergen Braun et al.
RHEUMATOLOGY (2019)
Interleukin-17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis
Melissa N. van Tok et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Accelerated osteogenic differentiation of human bone-derived cells in ankylosing spondylitis
Sungsin Jo et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2018)
Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-κB pathways
Chang-hong Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Inflammation Intensity-Dependent Expression of Osteoinductive Wnt Proteins Is Critical for Ectopic New Bone Formation in Ankylosing Spondylitis
Xiang Li et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases
Ariane Hammitzsch et al.
SCIENTIFIC REPORTS (2018)
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial
Desiree van der Heijde et al.
LANCET (2018)
IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
Sungsin Jo et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
Juergen Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis
Katelijne De Wilde et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The emerging safety profile of JAK inhibitors in rheumatic disease
Kevin L. Winthrop
NATURE REVIEWS RHEUMATOLOGY (2017)
Stat3 as a potential therapeutic target for rheumatoid arthritis
Takatsugu Oike et al.
SCIENTIFIC REPORTS (2017)
Regulatory role of the JAK STAT kinase signalling system on the IL-23/IL-17 cytokine axis in psoriatic arthritis
Smriti K. Raychaudhuri et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
STAT3 signaling in immunity
Emily J. Hillmer et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Psoriatic Inflammation Facilitates the Onset of Arthritis in a Mouse Model
Mayuko Yamamoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Animal Models as a Tool to Dissect Pivotal Pathways Driving Spondyloarthritis
Elsa Vieira-Sousa et al.
ARTHRITIS & RHEUMATOLOGY (2015)
The Interleukin-23/Interleukin-17 Axis in Spondyloarthritis Pathogenesis Th17 and Beyond
Judith A. Smith et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Interleukin-23 Mediates the Intestinal Response to Microbial β-1,3-Glucan and the Development of Spondyloarthritis Pathology in SKG Mice
Helen Benham et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
Adrian Cortes et al.
NATURE GENETICS (2013)
Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of treg cells
Ji Hyeon Ju et al.
ARTHRITIS AND RHEUMATISM (2012)
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis
Francesco Ciccia et al.
ARTHRITIS AND RHEUMATISM (2012)
The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells
Keisuke Maeshima et al.
ARTHRITIS AND RHEUMATISM (2012)
β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice
Merja Ruutu et al.
ARTHRITIS AND RHEUMATISM (2012)
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells
Jonathan P. Sherlock et al.
NATURE MEDICINE (2012)
Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and Homeostasis
Lydia Durant et al.
IMMUNITY (2010)
Clinical spectrum of ankylosing spondylitis in Korea
Tae-Jong Kim et al.
JOINT BONE SPINE (2010)
Bone Morphogenetic Protein 2 and Dexamethasone Synergistically Increase Alkaline Phosphatase Levels Through JAK/STAT Signaling in C3H10T1/2 Cells
Yoshikazu Mikami et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Association of Variants at 1q32 and STAT3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn's Disease
Patrick Danoy et al.
PLOS GENETICS (2010)
Progress in spondylarthritis Mechanisms of new bone formation in spondyloarthritis
Rik J. U. Lories et al.
ARTHRITIS RESEARCH & THERAPY (2009)
TH 17 cells in development:: an updated view of their molecular identity and genetic programming
Chen Dong
NATURE REVIEWS IMMUNOLOGY (2008)
A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R
C Parham et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
